Effect of Licofelone—A Dual COX/5-LOX Inhibitor in Intracerebroventricular Streptozotocin-Induced Behavioral and Biochemical Abnormalities in Rats

Journal of Molecular Neuroscience

Volumn 55, Issue 3, 2015, Pages 749-759

  Kumar, Ashok ^a   Sharma, Sorabh ^a   Prashar, Ashwani ^a   Deshmukh, Rahul ^a  

^a ISF COLLEGE OF PHARMACY   (India)

Author keywords

Alzheimer s disease; Cyclooxygenase; Licofelone; Lipoxygenase; Oxidative stress; Streptozotocin

Indexed keywords

ACETYLCHOLINESTERASE; GLUTATHIONE; INTERLEUKIN 1BETA; LICOFELONE; MALONALDEHYDE; NITRITE; STREPTOZOCIN; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; LIPOXYGENASE INHIBITOR; PROSTAGLANDIN SYNTHASE INHIBITOR; PYRROLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; ENZYME ACTIVITY; LOCOMOTION; MALE; MEMORY; MORRIS WATER MAZE TEST; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; OXIDATIVE STRESS; PASSIVE AVOIDANCE; RAT; TREATMENT DURATION; ALZHEIMER DISEASE; ANIMAL; AVOIDANCE BEHAVIOR; GENETICS; MAZE TEST; METABOLISM; WISTAR RAT;

RATTUS;

ACETYLCHOLINESTERASE; ALZHEIMER DISEASE; ANIMALS; AVOIDANCE LEARNING; CYCLOOXYGENASE INHIBITORS; CYTOKINES; GLUTATHIONE; LIPOXYGENASE INHIBITORS; MALE; MALONDIALDEHYDE; MAZE LEARNING; OXIDATIVE STRESS; PYRROLES; RATS; RATS, WISTAR; STREPTOZOCIN;

EID: 84922266378     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-014-0414-4     Document Type: Article

References (76)

1. Andreasson KI, Savonenko A, Vidensky S, Goellner JJ, Zhang Y, Shaffer A et al (2001) Age-dependent cognitive deficits and neuronal apoptosis in cyclooxygenase-2 transgenic mice. J Neurosci 21:8198–8209
2. Baran H, Vass K, Lassmann H, Hornykiewicz O (1994) The cyclooxygenase and lipoxygenase inhibitor BW755C protects rats against kainic acid-induced seizures and neurotoxicity. Brain Res 646:201–206
3. Barker GRI, Warburton CE (2009) Critical role of the cholinergic system for object-in-place associative recognition memory. Learn Mem 16:8–11
4. Bishnoi M, Bosgraaf CA, Abooj M, Zhong L, Premkumar LS (2011) Streptozotocin-induced early thermal hyperalgesia is independent of glycemic state of rats: role of transient receptor potential vanilloid 1 (TRPV1) and inflammatory mediators. Mol Pain 7:1–11
5. Bruce-Keller AJ, Li YJ, Lovell MA, Kraemer PJ, Gary DS, Brown RR et al (1998) 4-Hydroxynonenal, a product of lipid peroxidation, damages cholinergic neurons and impairs visuospatial memory in rats. J Neuropathol Exp Neurol 57:257–267
6. Butcher LL, Woolf NJ, Scheibel AB, Weschsler AF (1986) Central cholinergic systems: synopsis of anatomy and overview of physiology and pathology. The biological substrate of Alzheimer’s diseases. Academic, New York, pp 73–86
7. Calanni F, Laufer S (2003) Biochemistry and mediators of inflammation. In: Laufer S, Gay S, Brune K (eds) Inflammation and rheumatic diseases. The molecular basis of novel therapies. Georg Thieme Verlag, Stuttgart, pp 15–57
8. Candelario-Jalil E, Alvarez D, Merino N, Leon OS (2003) Delayed treatment with nimesulide reduces measures of oxidative stress following global ischemic brain injury in gerbils. Neurosci Res 47:245–253
9. Consilvio C, Vincent AM, Feldman EL (2004) Neuroinflammation, COX-2, and ALS—a dual role? Exp Neurol 187:1–10
10. Deshmukh R, Sharma V, Mehan S, Sharma N, Bedi KL (2009) Amelioration of intracerebroventricular streptozotocin induced cognitive dysfunction and oxidative stress by vinpocetine—a PDE1 inhibitor. Eur J Pharmacol 620:49–56
11. Dhull DK, Jindal A, Dhull RK, Aggarwal S, Bhateja D, Padi SSV (2011) Neuroprotective effect of cyclooxygenase inhibitors in ICV-STZ induced sporadic Alzheimer’s disease in rats. J Mol Neurosci 46(1):223–235
12. Di Bona D, Plaia A, Vasto S, Cavallone L, Lescai F, Franceschi C et al (2008) Association between the interleukin-1β polymorphisms and Alzheimer’s disease: a systematic review and meta-analysis. Brain Res Rev 59:155–163
13. Di Bona D, Vasto S, Capurso C, Christiansen L, Deiana L, Franceschi C et al (2009) Effect of interleukin-6 polymorphisms on human longevity: a systematic review and meta-analysis. Ageing Res Rev 8:36–42
14. Dulin JN, Karoly ED, Wang Y, Strobel HW, Grill RJ (2013) Licofelone modulates neuroinflammation and attenuates mechanical hypersensitivity in the chronic phase of spinal cord injury. J Neurosci 33:652–664
15. Edison P, Archer HA, Gerhard A, Hinz R, Pavese N, Turkheimer FE et al (2008) Microglia, amyloid, and cognition in Alzheimer’s disease: an [11C](R)PK11195-PET and [11C]PIB-PET study. Neurobiol Dis 32:412–419
16. Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82:70–77
17. Ellman GL, Courtney KD, Andres V, Featherstone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88–95
18. Everitt BJ, Robbins TW (1997) Central cholinergic systems and cognition. Annu Rev Psychol 48:649–684
19. Fillit H, Ding WH, Buee L, Kalman J, Altstiel L, Lawlor B et al (1991) Elevated circulating tumor necrosis factor levels in Alzheimer’s disease. Neurosci Lett 129:318–320
20. Firuzi O, Zhuo J, Chinnici CM, Wisniewski T, Pratico D (2008) 5-Lipoxygenase gene disruption reduces amyloid-beta pathology in a mouse model of Alzheimer’s disease. FASEB J 22:1169–1178
21. Gotz J, Gotz NN (2009) Animal models for Alzheimer’s disease and frontotemporal dementia: a perspective. ASN Neuro 1:251–264
22. Green LC, Wagner DA, Glgowski J, Skipper PL, Wishnok JS, Tannebaum SR (1982) Analysis of nitrate, nitrite and [15 N] nitrate in biological fluids. Ann Biochem Exp Med 126:131–135
23. Griffin WST, Stanley LC, Ling C, White L, Macleod V, Perrot LJ (1989) Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci U S A 86:7611–7615
24. Haense C, Kalbe E, Herholz K, Hohmann C, Neumaier B, Krais R, Heiss WD (2012) Cholinergic system function and cognition in mild cognitive impairment. Neurobiol Aging 33:867–877
25. Hein AM, O’Banion MK (2009) Neuroinflammation and memory: the role of prostaglandins. Mol Neurobiol 40:15–32
26. Hein AM, Stutzman DL, Bland ST, Barrientos RM, Watkins LR, Rudy JW et al (2007) Prostaglandins are necessary and sufficient to induce contextual fear learning impairments after interleukin-1 beta injections into the dorsal hippocampus. Neuroscience 150:754–763
27. Ishrat T, Hoda MN, Khan MB, Yousuf S, Ahmad M, Khan MM et al (2009) Amelioration of cognitive deficits and neurodegeneration by curcumin in rat model of sporadic dementia of Alzheimer’s type (SDAT). Eur Neuropsychopharmacol 21:1–12
28. Kalonia H, Kumar P, Kumar A (2011) Licofelone attenuates quinolinic acid induced Huntington like symptoms: possible behavioral, biochemical and cellular alterations. Prog Neuropsychopharmacol Biol Psychiatry 35:607–615
29. Klegeris A, McGeer PL (2002) Cyclooxygenase and 5-lipoxygenase inhibitors protect against mononuclear phagocyte neurotoxicity. Neurobiol Aging 23:787–794
30. Kumar A, Seghal N, Padi SSV, Naidu PS (2006a) Differential effects of cyclooxygenase inhibitors on intracerebroventricular colchicines induced dysfunction and oxidative stress in rats. Eur J Pharmacol 551:58–66
31. Kumar P, Padi SSV, Naidu PS, Kumar A (2006b) Effect of resveratrol on 3-nitropropionic acid-induced biochemical and behavioural changes: possible neuroprotective mechanisms. Behav Pharmacol 17:485–492
32. Kumar A, Vashist A, Kumar P, Kalonia H, Mishra J (2012) Potential role of licofelone, minocycline and their combination against chronic fatigue stress induced behavioral, biochemical and mitochondrial alterations in mice. Pharmacol Rep 64:1105–1115
33. Lammers CH, Schweitzer P, Facchinetti P, Arrang JM, Madamba SG, Siggins GR et al (1996) Arachidonate 5-lipoxygenase and its activating protein: prominent hippocampal expression and role in somatostatin signaling. J Neurochem 66:147–152
34. Lima IVA, Bastos LFS, Filho ML, Fiebich BL, Oliveira ACP (2012) Role of prostaglandins in neuroinflammatory and neurodegenerative diseases. Mediat Inflamm 2012:1–13
35. Liu R, Liu IY, Bi X, Thompson RF, Doctrow SR, Malfroy B et al (2001) Reversal of age-related learning deficits and brain oxidative stress in mice with superoxide dismutase/catalase mimetics. Proc Natl Acad Sci U S A 100:8526–8531
36. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
37. Madrigal JLM, Moro MA, Lizasoain I, Lorenzo P, Fernandez AP, Rodrigo J et al (2003) Induction of cyclooxygenase-2 accounts for restraint stress-induced oxidative status in rat brain. Neuropsychopharmacology 28:1579–1588
38. Mangialasche F, Polidori MC, Monastero R, Ercolani S, Camarda C, Cecchetti R et al (2009) Biomarkers of oxidative and nitrosative damage in Alzheimer’s disease and mild cognitive impairment. Aging Res Rev 8:285–305
39. Mao P (2012) Oxidative stress and its clinical applications in dementia. J Neurodegener Dis 1–15
40. Mao P, Reddy PH (2011) Aging and amyloid beta-induced oxidative DNA damage and mitochondrial dysfunction in Alzheimer’s disease: implications for early intervention and therapeutics. Biochim Biophys Acta 1812:1359–1370
41. Matsumoto Y, Yamaguchi T, Watanabe S, Yamamoto T (2004) Involvement of arachidonic acid cascade in working memory impairment induced by interleukin-1 beta. Neuropharmacology 46:1195–1200
42. Melnikova T, Savonenko A, Wang Q, Liang X, Hand T, Wu L et al (2006) Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer’s disease in a sex-dimorphic pattern. Neuroscience 141:1149–1162
43. Miranda MI, Ferreira G, Ramirez-Lugo L, Bermudez-Rattoni F (2003) Role of cholinergic system on the construction of memories: taste memory encoding. Neurobiol Learn Mem 80:211–222
44. Montine TJ, Sidell KR, Crews BC, Markesbery WR, Marnett LJ, Roberts LJ (1999) Elevated CSF prostaglandin E2 levels in patients with probable AD. Neurology 53:1495–1498
45. Morris RGM (1984) Development of a water-maze procedure for studying spatial learning in the rats. J Neurosci Methods 11:47–60
46. O’Banion MK (1999) COX-2 and Alzheimer’s disease: potential roles in inflammation and neurodegeneration. Expert Opin Investig Drugs 8:1521–1536
47. Pasinetti GM, Aisen PS (1998) Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer’s disease brain. Neuroscience 87:319–324
48. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, 2nd edn. Academic, San Diego
49. Pepicelli O, Fedele E, Bonanno G, Raiteri M, Ajmone-Cat MA, Greco A et al (2002) In vivo activation of N-methyl-D-aspartate receptors in the rat hippocampus increases prostaglandin E-2 extracellular levels and triggers lipid peroxidation through cyclooxygenase-mediated mechanisms. J Neurochem 81:1028–1034
50. Popic P, Nalepa I, Mamczarz J, Vetulani J (1994) Retrieval associated cholinergic activity and its inhibition by memory updating. Life Sci 54:1251–1257
51. Pratico D (2002) Alzheimer’s disease and oxygen radicals: new insights. Biochem Pharmacol 63:563–567
52. Pratico D (2008) Evidence of oxidative stress in Alzheimer’s disease brain and antioxidant therapy: lights and shadows. Ann N Y Acad Sci 1147:70–78
53. Pratico D, Zhukareva V, Yao Y, Uryu K, Funk CD, Lawson JA et al (2004) 12/15-Lipoxygenase is increased in Alzheimer’s disease: possible involvement in brain oxidative stress. Am J Pathol 164:1655–1662
54. Rai S, Kamat PK, Nath C, Shukla R (2012) A study on neuroinflammation and NMDA receptor function in STZ (ICV) induced memory impaired rats. J Neuroimmunol 254(1–2):1–9
55. Salkovic-Petrisic M (2008) Amyloid cascade hypothesis: is it true for sporadic Alzheimer’s disease. Period Biologrum 110:17–25
56. Salkovic-Petrisic M, Hoyer S (2007) Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach. J Neural Transm 72:217–233
57. Sarter M, Parikh V (2005) Choline transporters, cholinergic transmission and cognition. Nat Rev Neurosci 6:48–56
58. Shaftel SS, Kyrkanides S, Olschowka JA, Miller JH, Johnson RE, O’Banion MK (2007) Sustained hippocampal IL-1β overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology. J Clin Invest 117:1595–1604
59. Shaftel SS, Griffin WST, O’Banion MK (2008) The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective. J Neuroinflammation 5:1–12
60. Sharma N, Deshmukh R, Bedi KL (2010) SP600125, a competitive inhibitor of JNK attenuates streptozotocin induced neurocognitive deficit and oxidative stress in rats. Pharmacol Biochem Behav 96:386–394
61. Sharma V, Bala A, Deshmukh R, Bedi KL, Sharma PL (2012) Neuroprotective effect of RO-20-1724-a phosphodiesterase4 inhibitor against intracerebroventricular streptozotocin induced cognitive deficit and oxidative stress in rats. Pharmacol Biochem Behav 101:239–245
62. Shoham S, Bejar C, Kovalev E, Schorer-Apelbaum D, Weinstock M (2007) Ladostigil prevents gliosis, oxidative–nitrative stress and memory deficits induced by intracerebroventricular injection of streptozotocin in rats. Neuropharmacology 52:836–843
63. Singh VP, Patil CS, Kulkarni SK (2006) Anti-inflammatory effect of licofelone against various inflammatory challenges. Fundam Clin Pharmacol 20:65–71
64. Smith WL, DeWitt DL, Garavito RM (2000) Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 69:145–182
65. Song MS, Rauw G, Baker GB, Kar S (2008) Memantine protects rat cortical cultured neurons against beta-amyloid-induced toxicity by attenuating tau phosphorylation. Eur J Neurosci 28:1989–2002
66. Sonkusare S, Srinivasan K, Kaul C, Ramarao P (2005) Effect of donepezil and lercanidipine on memory impairment induced by intracerebroventricular streptozotocin in rats. Life Sci 77:1–14
67. Tahirovic I, Sofic E, Sapcanin A (2007) Reduced brain antioxidant capacity in rat models of betacytotoxic-induced impairment induced by interleukin-1 beta. Neuropharmacology 46:1195–1200
68. 1 R-mediated amyloid-β generation in mice. Neuropharmacology 65:182–192
69. Tuppo EE, Arias HR (2005) The role of inflammation in Alzheimer’s disease. Int J Biochem Cell Biol 37:289–305
70. Wang XL, Su B, Zheng L, Perry G, Smith MA, Zhu XW (2009) The role of abnormal mitochondrial dynamics in the pathogenesis of Alzheimer’s disease. J Neurochem 109:153–159
71. Wang XY, Tang SS, Hu M, Long Y, Li YQ, Liao MX et al (2013) Leukotriene D4 induces amyloid-β generation via CysLT(1)R-mediated NF-κB pathways in primary neurons. Neurochem Int 62:340–347
72. Wickens AP (2001) Ageing and the free radical theory. Respir Physiol 28:379–391
73. Wills ED (1996) Mechanism of lipid peroxide formation in animal. Biochem J 99:667–676
74. Wyss-Coray T (2006) Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat Med 12:1005–1015
75. Xiang Z, Ho L, Valdellon J, Borchelt D, Kelley K, Spielman L et al (2002) Cyclooxygenase (COX)-2 and cell cycle activity in a transgenic mouse model of Alzheimer’s disease neuropathology. Neurobiol Aging 23(3):327–334
76. Yao Y, Clark CM, Trojanowski JQ, Lee VM, Pratico D (2005) Elevation of 12/15 lipoxygenase products in AD and mild cognitive impairment. Ann Neurol 58:623–626